SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HerbVic who wrote ()4/7/1999 10:27:00 PM
From: neelu  Read Replies (2) of 253
 
OHSI is definitely a buy. Trading at 3 1/2 its at book. Unlike many refractive comp, this one consistantly makes a profit. Last year LASIK-5000-run rate this year should exceed 9000. And now with the addition of 12 Visx unit, a facility fee of 890 in addition will drive the bottom line. Should see this in stock price 6-12 mths. Also with the sale of EHN to a strategic partner in the second quater-should help as well
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News